{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:29:34Z","timestamp":1789504174773,"version":"build-2803163510"},"reference-count":46,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["alz-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Alzheimer's &amp;amp; Dementia"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Numerous patient\u2010 and disease\u2010related factors increase the risk of rapid cognitive decline in patients with Alzheimer's disease (AD). The ability of pharmacological treatment to attenuate this risk remains undefined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Pooled data from 14 randomized clinical studies of donepezil in the treatment of AD (N = 3748) were analyzed to identify predictors of fast decline and determine the effect of donepezil on the risk of fast decline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Young age and more severe baseline cognitive, global, or behavioral status were identified as independent predictors of faster decline in placebo\u2010treated patients. Multivariate models indicated that donepezil treatment was associated with a 39% to 63% reduction in the risk of faster decline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These results correspond with previous findings, indicating relationships between age or baseline disease severity and rates of cognitive decline. Furthermore, they suggest that symptomatic therapy for AD could reduce the likelihood of faster decline in treated patients.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.jalz.2010.04.003","type":"journal-article","created":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T04:13:11Z","timestamp":1288584791000},"page":"431-439","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Predicting cognitive decline in Alzheimer's disease: An integrated analysis"],"prefix":"10.1002","volume":"6","author":[{"given":"Oscar L.","family":"Lopez","sequence":"first","affiliation":[{"name":"Department of Neurology, Alzheimer's Disease Research Center University of Pittsburgh Pittsburgh PA USA"},{"name":"Department of Psychiatry, Alzheimer's Disease Research Center University of Pittsburgh Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Schwam","sequence":"additional","affiliation":[{"name":"Pfizer Global Pharmaceuticals, Pfizer Inc New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Cummings","sequence":"additional","affiliation":[{"name":"Mary S. Easton Center for Alzheimer's Disease Research UCLA Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Gauthier","sequence":"additional","affiliation":[{"name":"McGill Center for Studies in Aging Douglas Mental Health University Institute, Douglas Hospital Verdun Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Jones","sequence":"additional","affiliation":[{"name":"RICE (Research Institute for the Care of Older People) Royal United Hospital Bath United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Memory Assessment and Research Centre Moorgreen Hospital Southampton United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild","family":"Waldemar","sequence":"additional","affiliation":[{"name":"Memory Disorders Research Group Copenhagen University Hospital, Rigshospitalet Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pfizer Global Pharmaceuticals, Pfizer Inc New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Schindler","sequence":"additional","affiliation":[{"name":"Pfizer Global Pharmaceuticals, Pfizer Inc New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.7.1215"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-200110000-00003"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1006\/brcg.1996.0038"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550200033007"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01693.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-9452(13)80264-X"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.acn.2003.12.011","article-title":"Investigation of profile difference between Alzheimer's disease patients declining at different rates: examination of baseline neuropsychological data","volume":"19","author":"Atchison T.B.","year":"2004","journal-title":"Arch Clin Neuropsychol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.10.1649"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.12.2300"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1994.00540190056015"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.6.1521"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.12.1755"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000162054.15428.E9"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.3.532"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1341"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53015.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106895"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.136"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.9.1021"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017126"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017259"},{"issue":"1","key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/S0197-4580(00)82100-4","article-title":"Effect of donepezil treatment on visual attention\/exploration tasks in patients with mild to moderately severe Alzheimer's disease: results of a pilot study","volume":"21","author":"Geldmacher D.S.","year":"2000","journal-title":"Neurobiol Aging"},{"key":"e_1_2_6_24_2","article-title":"A 1\u2010year, placebo\u2010controlled preservation of function survival study of donepezil in AD patients","volume":"57","author":"Mohs R.C.","year":"2001","journal-title":"Neurology"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.4.613"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.3.489"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2001.49266.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-200303000-00007"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.11.2003"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1133"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.11.1356"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.3.390"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610293001474"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2006.03.002"},{"key":"e_1_2_6_36_2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF03028618","article-title":"Rapid cognitive decline in Alzheimer's disease. Consensus paper","volume":"12","author":"Soto M.E.","year":"2008","journal-title":"J Nutr Health Aging"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1975.00490510088009"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.12.2308"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31819cd4be"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2008-14304"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0313"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000187889.17253.b1"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/089198879901200408"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.15.3.346"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291703001831"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-198802040-00003"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/30.2.206"}],"container-title":["Alzheimer's &amp; Dementia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1552526010001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1552526010001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.jalz.2010.04.003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.jalz.2010.04.003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1016\/j.jalz.2010.04.003","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.jalz.2010.04.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:14:39Z","timestamp":1759936479000},"score":1,"resource":{"primary":{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1016\/j.jalz.2010.04.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1016\/j.jalz.2010.04.003"],"URL":"https:\/\/doi.org\/10.1016\/j.jalz.2010.04.003","archive":["Portico"],"relation":{},"ISSN":["1552-5260","1552-5279"],"issn-type":[{"value":"1552-5260","type":"print"},{"value":"1552-5279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"2010-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}